Awardee OrganizationUNIVERSITY OF TEXAS MED BR GALVESTON
Description
Abstract Text
DESCRIPTION (provided by applicant): Our work focuses on IGF-I regulation of gene expression for P-450 cholesterol side-chain cleavage (P450scc), the rate-limiting enzyme in the steroidogenic pathway. We identified an IGF-I response element (IGFRE) of the porcine P450scc gene that binds Sp1(stimulator) and polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF, repressor).
In this proposal we will investigate mechanisms of PSF regulation of IGFRE activity. Studies will be conducted in a stable porcine granulosa cell line, the JC-410 cells. We hypothesize that PSF repression of the IGFRE involves a mechanism that prevents IGF-I-stimulated phosphorylation of Sp1. In specific aim 1 we will determine IGF-I-mediated Sp1 phosphorylation sites having already demonstrated that IGF-I stimulates phosphorylation of threonine 739 on Sp1, a known erk 1/2 phosphorylation site. In specific aim 2 we will investigate the erk 1/2 signaling pathway as at least a partial mechanism for regulating IGF-I stimulation of the IGFRE through Sp1 phosphorylation. Finally, we will investigate protein kinase C (PKC) iota as a modulator of PSF-Sp1 interactions regulating the IGFRE (specific aim 3).
We will determine the fundamental mechanisms whereby IGF-I controls P450scc gene expression through interactions of Sp1, PSF, and PKC iota. This knowledge will increase our understanding and provide the basic background for novel concepts on hormonal control of ovarian steroidogenesis.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA binding proteinRNA binding proteinantisense nucleic acidcell linecholesterolchromatin immunoprecipitationcytochrome P450enzyme activityenzyme mechanismenzyme structuregene expressiongenetic regulatory elementgranulosa cellinsulinlike growth factormitogen activated protein kinasemolecular siteoligonucleotidesphosphorylationprotein kinase Cprotein protein interactionrecombinant proteinssteroid biosynthesisthreoninetranscription factor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
800771149
UEI
MSPWVMXXMN76
Project Start Date
01-December-2004
Project End Date
30-November-2009
Budget Start Date
01-December-2004
Budget End Date
30-November-2005
Project Funding Information for 2005
Total Funding
$271,800
Direct Costs
$180,000
Indirect Costs
$91,800
Year
Funding IC
FY Total Cost by IC
2005
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$271,800
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD044566-01A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD044566-01A2
Patents
No Patents information available for 1R01HD044566-01A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD044566-01A2
Clinical Studies
No Clinical Studies information available for 1R01HD044566-01A2
News and More
Related News Releases
No news release information available for 1R01HD044566-01A2
History
No Historical information available for 1R01HD044566-01A2
Similar Projects
No Similar Projects information available for 1R01HD044566-01A2